ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Revelation Biosciences Inc

Revelation Biosciences Inc (REVB)

0.36
-0.0526
(-12.75%)
Closed December 14 3:00PM
0.371
0.011
(3.06%)
After Hours: 6:21PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.371
Bid
0.37
Ask
0.371
Volume
534,428
0.338 Day's Range 0.3926
0.3606 52 Week Range 25.26
Market Cap
Previous Close
0.4126
Open
0.39
Last Trade
1
@
0.37
Last Trade Time
Financial Volume
US$ 192,251
VWAP
0.359732
Average Volume (3m)
1,040,904
Shares Outstanding
4,292,455
Dividend Yield
-
PE Ratio
-0.36
Earnings Per Share (EPS)
-0.03
Revenue
-
Net Profit
-120k

About Revelation Biosciences Inc

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Headquarters
Lewes, Delaware, USA
Founded
2022
Revelation Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker REVB. The last closing price for Revelation Biosciences was US$0.41. Over the last year, Revelation Biosciences shares have traded in a share price range of US$ 0.3606 to US$ 25.26.

Revelation Biosciences currently has 4,292,455 shares outstanding. The market capitalization of Revelation Biosciences is US$1.77 million. Revelation Biosciences has a price to earnings ratio (PE ratio) of -0.36.

REVB Latest News

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment...

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

-Phase 1b Study in CKD Patients to begin early 2025- Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage life sciences company that is focused on...

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...

Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10

Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention...

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Revelation Biosciences Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of...

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Revelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0721-16.27172195890.44310.4650.36065126120.43339137CS
4-0.4405-54.28219346890.81150.9760.360616351570.67032959CS
12-0.499-57.35632183910.871.050.360610409040.81616889CS
26-1.919-83.79912663762.293.80.360615734771.6856617CS
52-15.829-97.709876543216.225.260.36069255222.44109725CS
156-8798.629-99.9957836118879910237.50.36061273007771.75728195CS
260-8798.629-99.9957836118879910237.50.36061273007771.75728195CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WKEYWISeKey International Holdings AG
US$ 7.84
(139.02%)
75.53M
IPHAInnate Pharma SA
US$ 3.00
(93.55%)
13.59M
AVLDirexion Daily AVGO Bull 2X Shares
US$ 33.67
(48.92%)
658.55k
LOOPLoop Industries Inc
US$ 1.8092
(47.09%)
82.56M
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 31.49
(46.67%)
3.55M
RPTXRepare Therapeutics Inc
US$ 1.765
(-55.54%)
4.59M
INOInovio Pharmaceuticals Inc New
US$ 2.31
(-38.56%)
9.59M
XXII22nd Century Group Inc
US$ 0.048
(-34.69%)
41.72M
FLGCFlora Growth Corporation
US$ 1.30
(-34.34%)
4.01M
WTOUTime Limited
US$ 0.281
(-32.74%)
3.79M
NVDANVIDIA Corporation
US$ 134.25
(-2.25%)
231.23M
SOUNSoundHound AI Inc
US$ 16.905
(23.66%)
159.56M
TRUGTruGolf Holdings Inc
US$ 0.6794
(30.93%)
141.89M
RGTIRigetti Computing Inc
US$ 7.155
(19.85%)
124.45M
AVGOBroadcom Inc
US$ 224.80
(24.43%)
121.33M

REVB Discussion

View Posts
Monksdream Monksdream 21 hours ago
REVB, new 52 week low
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 weeks ago
REVB BLAST INTO CLOSE
πŸ‘οΈ0
tw0122 tw0122 2 weeks ago
FDA clearance .85
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
REVB.................................https://stockcharts.com/h-sc/ui?s=REVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
tw0122 tw0122 1 month ago
Nice bump..+ 20% $1.07..
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024November 08 2024 - 4:15PM
Business WireRevelation Biosciences, Inc. (NASDAQ: REVB) (the β€œCompany” or β€œRevelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, today reported its three and nine months ended September 30, 2024 financial results.Corporate HighlightsCompleted GMP manufacture of Gemini clinical drug supplyReceived net proceeds of $3.8 million from the exercise of warrants in August 2024Announced Gemini induces dose dependent significant increases in IL-10 in healthy volunteersβ€œThe Revelation team continues to make significant progress on the advancement of Gemini,” said James Rolke, Chief Executive Officer of Revelation. β€œWe look forward to the anticipated acceptance of our IND by the FDA and building on this momentum with the start of our Phase 1b study in CKD patients in the United States.”Results of OperationsAs of September 30, 2024, Revelation had $6.5 million in cash and cash equivalents, compared to $12.0 million as of December 31, 2023. The decrease in cash and cash equivalents was primarily due to cash used for operating activities and the Lifesci Capital judgment, offset by net cash received from financing activities. Based on current operating plans and projections, Revelation believes that its current cash and cash equivalents are sufficient to fund operations into 2025.Revelation’s net cash used for operating activities for the nine months ended September 30, 2024 was $14.6 million compared to net cash used for operating activities of $5.3 million for the same period in 2023. Revelation’s net loss for the three months ended September 30, 2024 was $2.2 million, or $0.84 basic and diluted net loss per share compared to a net loss of $2.6 million, or $9.94 basic and diluted net loss per share for the same period in 2023. Revelation’s net loss for the nine months ended September 30, 2024 was $13.3 million, or $7.38 basic and diluted net loss per share compared to net income of $2.1 million, or $9.62 basic net earnings per share and $9.38 diluted net earnings per share for the same period in 2023, respectively.About GeminiGemini is a proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®) for systemic administration. It is being developed for multiple indications including as a pretreatment to prevent or reduce the severity and duration of post-surgical infection (GEMINI-PSI program), and as a pretreatment to prevent or reduce the severity and duration of acute kidney injury (GEMINI-AKI program). In addition, Gemini may be a treatment to stop or slow the progression of chronic kidney disease (GEMINI-CKD program). Revelation believes Gemini works through trained immunity, which redirects and attenuates the innate immune response to external stress (infection, trauma, etc.). Revelation has conducted multiple preclinical studies demonstrating the therapeutic potential of Gemini in the target indications.About Revelation Biosciences, Inc.Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as a prevention for acute kidney injury, and for the treatment of chronic kidney disease.
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
REVB......................................https://stockcharts.com/h-sc/ui?s=REVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
REVB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
REVB under $2
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
REVB........................https://stockcharts.com/h-sc/ui?s=REVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
REVBW: Are ya all READY for the greatest stock price EXPLOSION in the entire history of WALL STREET!!! (Second only to the legendary @HKD run-up, the iHub board for which I myself created!!!)


WIFE: "Oh--my-God, Tom!!! Was that the Russian Satan-II Bomb going off here in our wonderful San Diego, California, US NAVY Fleet Harbor???!!!"
HUBBY: "Fret not, Honey --- it was just the explosion in the PRICE our REVB stock WARRANTS."
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
REVB..........................https://stockcharts.com/h-sc/ui?s=REVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
REVB: Whoops, the MONKSTER did it again!! (See him below in action, LIVE right now!!!)


"Oh-my-God!!! I see a 52-YEAR low for my LOVE LIFE --- approaching in precisely 6-DAYS!!!"
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
πŸ‘οΈ0
subslover subslover 4 months ago
PRE MKT SIZZLE!
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
REVB new 52=w e ek low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
REVB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
REVB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
REVB under $2
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
REVB under $2
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
Whoops, I did it, again
πŸ‘οΈ0
Awl416 Awl416 6 months ago
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
REVB new 52 low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
REVB new 52=week low
πŸ‘οΈ0
madras50 madras50 9 months ago
is this ever going to move?..up?
πŸ‘οΈ0
tw0122 tw0122 10 months ago
Added more 2.80s here like chart longer term have to start somewhere
👍️ 1
TheFinalCD TheFinalCD 10 months ago
https://stockcharts.com/h-sc/ui?s=REVB
πŸ‘οΈ0
Peter Penny Peter Penny 10 months ago
5-10$ tm weeeer
👍️ 1
Awl416 Awl416 10 months ago
Covering into close
πŸ‘οΈ0
Peter Penny Peter Penny 10 months ago
Going to moon here picked up 5k low 3s
👍️ 1
Monksdream Monksdream 10 months ago
REVB new 52 week low
🌈 1 🍆 1 👎️ 1 🩳 1
Stockexpertpro Stockexpertpro 10 months ago
MDVL Wow Stocks Down -60% on 9k Volume dont see any news
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
REVB new 52 week low
πŸ‘οΈ0
Awl416 Awl416 10 months ago
25 bucks to 3 bucks. Don’t blink
πŸ‘οΈ0
surf1944 surf1944 10 months ago
Covered REVB short position!
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 10 months ago
REVB 66$ Cash Per Share Trading at 7.60$ Trading nearly 60$ Per share Under Cash 175K Float total shares outstanding is 210k Market cap 1.5 Million VS Cash 14 Million in Cash https://finance.yahoo.com/quote/REVB/key-statistics?p=REVB
πŸ‘οΈ0
Invest-in-America Invest-in-America 11 months ago
REVB: Touche, Girl!!! (NOBODY can out-wit Her Majesty, Empress-CJ-The-Second!!! (GOOD LUCK though, with your MGRX --- you will NEED it to get its price UP --- no pun intended!!)
πŸ‘οΈ0
Carjockey2 Carjockey2 11 months ago
$REVB needs some MGRX 🥭

πŸ‘οΈ0
Invest-in-America Invest-in-America 11 months ago
REVB: And then, "The-Hot-Dog-Fell-Off-The-Mustard"!!!

πŸ‘οΈ0
surf1944 surf1944 11 months ago
https://stockcharts.com/h-sc/ui?s=revb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/revb/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/revb/opinion

https://finance.yahoo.com/quote/revb/

Short setup with REVB!
πŸ‘οΈ0
Carjockey2 Carjockey2 11 months ago
Oh babes!!!

πŸ‘οΈ0
elks elks 11 months ago
Looks like already hit 23 pre market.
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 11 months ago
REVB 175K Float With 66$+ Cash Per Share Trading at 16$ https://finance.yahoo.com/quote/REVB/key-statistics?p=REVB
👍️ 1
Carjockey2 Carjockey2 11 months ago
Thank you..

Looks like you're going to be right

πŸ‘οΈ0
tw0122 tw0122 11 months ago
REVB $16.43 catch a dip for the flip..still looks good moving forward a break of $25 and can see all the way up to $40- $45 zone. One of the good plays of the day
πŸ‘οΈ0
reena969 reena969 11 months ago
Your in on this also $$$$ Going to be crazy, Big money is going to play with this...HOLD ON TIGHT

Happy Trading
πŸ‘οΈ0
TheFinalCD TheFinalCD 11 months ago
$revb got 12.25 dip
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
REVB new 52 week low
πŸ‘οΈ0
elks elks 11 months ago
Here we go Revb next time i post it be at 20. Then 30 so on.
πŸ‘οΈ0
elks elks 11 months ago
Matter Time They will send it shares updated........buying under 10 bucks. outstanding shares 1/25 /2024 209,308 :)
πŸ‘οΈ0
elks elks 11 months ago
Got in 100 shares. REVB. Should Rocket soon. 200 k share float now.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock